Featured Tests

OmniSeq®

A complete testing portfolio powered by precision medicine.

OmniSeq Comprehensive Assay
OmniSeq Advance Assay
OmniSeq Immune Report Card® Assay

IntelliGEN® Myeloid

NGS assay covering 50 genes associated with myeloid malignancies

IntelliGEN® Myeloid


News & Announcements

PD-L1 (SP142) IHC in TNBC

Integrated Oncology now expands the offering of the VENTANA PD-L1 (SP142) IHC assay for use in metastatic triple-negative breast cancer (TNBC) tumor samples.  This companion diagnostic assay may help physicians determine which TNBC patients may benefit most with TECENTRIQ® (atezolizumab) plus chemotherapy.   Learn more

NTRK Gene Fusions

TRK fusion proteins are oncogenic drivers that occur in a broad range of tumors across adult and pediatric cancers. Genomic profiling using either the OmniSeq AdvanceSM assay or the OmniSeq Comprehensive® assay can identify actionable NTRK gene fusions for TRK inhibitor treatment selection.

OmniSeq Advance Assay OmniSeq Comprehensive Assay